|
ZNF484 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.1914999999968E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.05120000000126E-05 |
| Normal-vs-Stage2 |
5.084000E-02 |
| Normal-vs-Stage3 |
6.396200E-04 |
| Normal-vs-Stage4 |
2.829900E-02 |
| Stage1-vs-Stage2 |
2.190000E-01 |
| Stage1-vs-Stage3 |
8.586600E-01 |
| Stage1-vs-Stage4 |
8.065200E-01 |
| Stage2-vs-Stage3 |
2.982600E-01 |
| Stage2-vs-Stage4 |
5.585000E-01 |
| Stage3-vs-Stage4 |
8.857800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.023660E-04 |
| Normal-vs-AfricanAmerican |
5.164700E-04 |
| Normal-vs-Asian |
9.699200E-03 |
| Caucasian-vs-AfricanAmerican |
8.925400E-01 |
| Caucasian-vs-Asian |
4.935800E-01 |
| AfricanAmerican-vs-Asian |
4.397600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.86029999965842E-07 |
| Normal-vs-Female |
5.617900E-02 |
| Male-vs-Female |
1.682130E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.390900E-04 |
| Normal-vs-Extreme_Weight |
1.94004999999331E-05 |
| Normal-vs-Obese |
6.540400E-03 |
| Normal-vs-Extreme_Obese |
1.682310E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.403600E-01 |
| Normal_Weight-vs-Obese |
3.073000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.294200E-01 |
| Extreme_Weight-vs-Obese |
6.566300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.607000E-01 |
| Obese-vs-Extreme_Obese |
6.059200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.292280E-02 |
| Normal-vs-Age(41-60Yrs) |
7.764200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.1883999999629E-06 |
| Normal-vs-Age(81-100Yrs) |
1.372880E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.164400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.795200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.105200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.029570E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.577400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.071800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.71610000005074E-06 |
| Normal-VS-Type2 PRCC |
1.83570000000799E-06 |
| Normal-VS-KIRP CIMP |
2.514200E-01 |
| Normal-VS-Unclassified PRCC |
3.209800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.876200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.938560E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.057600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.629700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.236420E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.079000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.09440000009664E-07 |
| Normal-vs-N1 |
5.898000E-02 |
| Normal-vs-N2 |
1.748320E-02 |
| N0-vs-N1 |
7.242000E-02 |
| N0-vs-N2 |
5.393400E-01 |
| N1-vs-N2 |
2.503800E-01 |
|
|
